Results 21 to 30 of about 1,742,640 (300)
European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders [PDF]
: Background and purpose Patients with neuromuscular conditions are at increased risk of suffering perioperative complications related to anaesthesia. There is currently little specific anaesthetic guidance concerning these patients. Here, we present the
Díaz- Cambronero, Óscar +78 more
core +2 more sources
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
Background: 3,4-diaminopyridine (3,4-DAP) can lead to clinical and electrophysiological improvement in myasthenic syndrome; it may thus represent a valuable therapeutic option for patients intolerant to pyridostigmine.Objective: to assess 3,4 ...
Marco Ceccanti +9 more
doaj +1 more source
In the differential diagnosis of neuromuscular disorders, it is very important to know the family history of the patient, to perform a detailed physical examination, and to examine electrophysiological and biochemical analyses together.
Tiftikcioglu, Bedile Irem, Çolak, Ayfer
core +1 more source
Most mitochondrial dGTP is tightly bound to respiratory complex I through the NDUFA10 subunit
Mitochondrial dGTP is mostly bound to an accessory subunit of complex I of the mitochondrial respiratory chain, which may reveal a mechanism linking mitochondrial dNTP availability and oxidative metabolism.
David Molina-Granada +9 more
doaj +1 more source
OBJECTIVE: To discuss the most important aspects for the performance of a differential diagnosis among the main neuromuscular disorders in children, which include diseases affecting the motor unity, i.e. spinal motor neurons, peripheral nerves, neuromuscular junction and muscular fibers.
openaire +2 more sources
Hypoglycemia in patients with congenital muscle disease
Background Only a few small studies have previously reported episodes of hypoglycemia in children with neuromuscular diseases; however, there has been no broader investigation into the occurrence of hypoglycemia in children with congenital muscle disease
Leslie H. Hayes +10 more
doaj +1 more source
Poly-arginine peptide-18 (R18) has recently emerged as a highly effective neuroprotective agent in experimental stroke models, and is particularly efficacious in protecting cortical neurons against glutamic acid excitotoxicity.
Gabriella MacDougall +4 more
doaj +1 more source
Modes of Neuronal Calcium Entry and Homeostasis following Cerebral Ischemia
One of the major instigators leading to neuronal cell death and brain damage following cerebral ischemia is calcium dysregulation. The neuron's inability to maintain calcium homeostasis is believed to be a result of increased calcium influx and impaired ...
J. L. Cross +4 more
doaj +1 more source
Congenital muscular dystrophy type Ullrich (UCMD) is a severe disorder of early childhood onset for which currently there is no effective treatment. UCMD commonly is caused by dominant-negative mutations in the genes coding for collagen type VI, a major ...
Véronique Bolduc +3 more
doaj +1 more source
Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
Protein-truncating mutations in the dystrophin gene lead to the progressive muscle wasting disorder Duchenne muscular dystrophy, whereas in-frame deletions typically manifest as the milder allelic condition, Becker muscular dystrophy.
Sue Fletcher +9 more
doaj +1 more source

